Safety of COVID-19 vaccines in patients with non-communicable diseases: a protocol for systematic review and meta-analysis of randomised controlled trials
Introduction The COVID-19 global pandemic has posed enormous threats to public health around the world. Vaccines are considered the best therapeutic strategy against the COVID-19 pandemic. However, the adverse reactions of vaccines significantly affect the rates of vaccination and may be more seriou...
Saved in:
| Main Authors: | Chengqian Shi, Mizhi Wu, Xinchang Wang, Kepeng Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-05-01
|
| Series: | BMJ Open |
| Online Access: | https://bmjopen.bmj.com/content/12/5/e057233.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Helmet Non-Invasive Ventilation for COVID-19 Patients (Helmet-COVID): study protocol for a multicentre randomised controlled trial
by: Yaseen M Arabi, et al.
Published: (2021-08-01) -
Favipiravir for treating patients with novel coronavirus (COVID-19): protocol for a systematic review and meta-analysis of randomised clinical trials
by: Morteza Arab-Zozani, et al.
Published: (2020-07-01) -
Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial
by: Jie Li, et al.
Published: (2020-11-01) -
Metformin for covid-19: systematic review and meta-analysis of randomised controlled trials
by: Gordon Guyatt, et al.
Published: (2025-05-01) -
Prospective meta-analysis protocol on randomised trials of renin–angiotensin system inhibitors in patients with COVID-19: an initiative of the International Society of Hypertension
by: Anthony Rodgers, et al.
Published: (2021-02-01)